Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Leadership & People

Set Alert for Leadership & People

Executives On The Move: New CEOs At BerGenBio, Civetta, Jubilant And More

Novartis gets new People And Organization Officer, plus new CEOs at BerGenBio, Pillar Biosciences, Pascal Biosciences, Jubilant and Civetta Therapeutics.

Executive Changes BioPharmaceutical

Pharma On Its Back Foot As US Drug Price Reform Advances

Big pharma leaders warn of steep cuts to R&D and US jobs if US drug pricing reform legislation paves the way for direct government price negotiations.

Pricing Debate Politics

Executives On The Move: New Chief Business Innovation Officer For Pfizer

Aamir Malik leaves McKinsey & Co to join Pfizer as chief business innovation officer and executive vice president.

Executive Changes BioPharmaceutical

End Of An Era As Galapagos CEO Van De Stolpe Retires

Some 22 years after founding what was one of the biggest success stories in Europe's biotech sector before a recent series of setbacks in the clinic struck, Onno van de Stolpe has decided to retire as Galapagos CEO and the search has already started for his successor.

Executive Changes Business Strategies

Executives On The Move: New CMOs at Bone Therapeutics, Xenon Pharmaceuticals & Novan

Former Tmunity Therapeutics CFO Simona King joins Passage Bio as CFO. Rune Skeie, CFO of BerGenBio, holds the fort as interim CEO until Martin Olin joins in September.

Executive Changes BioPharmaceutical

J&J CEO Gorsky Handing Over The Reins To Vice Chairman Duato

Duato has been involved for the last several years in growing J&J’s pharma and consumer businesses and has led the company’s COVID-19 efforts. Gorsky is stepping down due to a family health issue.

Executive Changes Leadership

Executives On The Move: New Chief Financial Officers At Novavax, Yumanity

Adagene gets new chief medical officer, while Corcept Therapeutics gets new chief development officer from Gilead.

Executive Changes BioPharmaceutical

Musical Chairs: Lilly Leadership Changes Underscore Confidence In Donanemab Accelerated Approval

Oncology leader Anne White will oversee neuroscience and pain, while Bio-Medicines head Ilya Yuffa will take over for retiring Lilly International president; Loxo CEO will oversee entire oncology business. 

Leadership Executive Changes

Executives On The Move: New CEO At Stelis Biopharma, NuCana Picks Up Chief Medical Officer

New chief financial officers at Quiapeg Pharmaceuticals and Trevi Therapeutics.

Executive Changes BioPharmaceutical

Cautious Optimism For Alzheimer's Mounts Among Industry R&D Leaders

Some big pharma R&D leaders have signaled enhanced interest in neuroscience R&D – and Alzheimer's more specifically – following FDA's approval of Biogen's Aduhelm based on biomarkers.

Neurology Research & Development

Executives On The Move: New Chief Financial Officers At AstraZeneca, Cyxone

New chief medical officers at IGM Biosciences, Compass Pathways, Passage Bio and more.

Executive Changes BioPharmaceutical
See All